Global pharmaceutical company Sanofi will cut 466 jobs in France and Germany as it works to reorganize its research and development operations, according to EndPoints News.
The reorganization will allow Sanofi to refocus its R&D on cancer, immunology, rare diseases and vaccines. The company will end cardiology research.
Job cuts are voluntary. France has powerful unions that often challenge job cuts if they aren't voluntary, according to the report.